The largest database of trusted experimental protocols

19 protocols using anti cd19 6d5

1

Multimodal Analysis of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were isolated 72 hours after injection with LNPs unless otherwise noted. Mice were perfused with 20 mL of 1X PBS through the right atrium. Liver and lung tissues were finely minced, and then placed in a digestive enzyme solution with Collagenase Type I (Sigma Aldrich), Collagenase XI (Sigma Aldrich) and Hyaluronidase (Sigma Aldrich) at 37 ºC at 550 rpm for 45 minutes4,5. The spleen, bone marrow and thymus tissues were placed in 1X PBS solution. Cell suspension was filtered through 70μm mesh and red blood cells were lysed. Cells were stained to identify specific cell populations and sorted using the BD FacsFusion and BD Facs Aria IIIu cell sorters in the Georgia Institute of Technology Cellular Analysis Core. The antibody clones used were the following: anti‐CD31 (390, BioLegend), anti‐CD45.2 (104, BioLegend), anti‐CD68 (FA11, Biolegend), anti‐CD3 (17A2, Biolegend), anti‐CD19 (6D5, Biolegend), anti‐CD11b (M1/70, Biolegend), anit‐CD11c (N418, Biolegend), anti‐CD4 (GK1.5, Biolegend), anti‐CD8a (53‐6.7, Biolegend), anti‐CD34 (SA376A4, Biolegend), anti‐CD25 (3C7, Biolegend), anti‐CD326 (G8.8, Biolegend), and PE anti‐mCD47 (miap301, BioLegend). Representative flow gates are located in Supplementary Figure 3. PBS‐injected Ai14 mice were used to gate tdTomato populations for intravenous administration.
+ Open protocol
+ Expand
2

T-cell Phenotyping by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stained cells were analyzed using an LSRII system (BD Biosciences). Data were analyzed with a Diva software (BD Biosciences). Cell viability was evaluated using SYTOX Blue (Life Technologies). The following antibodies were used: anti-CD5 (53-7.3), anti-CD4 (RM4-5), anti-CD8α (53-6.7), anti-TCRγ (GL-3), anti-TCRβ (H57-597), all from BD Biosciences; anti-CD25 (PC61.5), and anti-CD19 (6D5) both from BioLegend. A CellTrace CFSE proliferation kit (Molecular Probes) was used.
+ Open protocol
+ Expand
3

Murine Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell suspensions were generated from murine tissues of C57/BL6 and BALB/c mice. Afterwards, cells were treated with FcR-blocking reagent (Miltenyi Biotec) for 10 min at 4°C after washing with flow cytometry buffer. To exclude dead cells, samples were washed twice with PBS and incubated with BD Horizon™ Fixable Viability Stain 510 viability dye (for 10 min at RT in the dark). Subsequently surface staining to discriminate immune cell populations with PerCP anti-CD45 (30-F11, BD Biosciences), APC-Cy 7 anti-TCRβ (H57-597, BioLegend), Pe-Cy7 anti-CD11b (M1/70, BD Biosciences), and anti-CD19 (6D5, BioLegend), was performed. The data was acquired using a BD FACS LSR II instrument (BD Biosciences) and analyzed with FlowJo software (Tree Star Inc, version 9.9.6 or 10.4.1).
+ Open protocol
+ Expand
4

Multiparameter Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleens and bone marrow (BM) from naïve mice were harvested from age- and sex-matched cohorts, and red blood cells were lysed by ammonium chloride lysis. Splenocytes were incubated for 30 minutes on ice with the following antibodies and dyes: viability (Zombie Aqua, Biolegend), anti-B220 (RA3–6B2, BD Biosciences), anti-CD19 (6D5, Biolegend), anti-CD23 (B3B4, Biolegend), anti-CD93 (AA4.1, Biolegend), anti-Ly77 (GL7, Biolegend), anti-IgD (11-26C.2a, Biolegend), anti-IgM (RMM1, Biolegend). and anti-F4/80 (BM8, Biolegend). BM was incubated for 30 minutes on ice with the following antibodies and dyes: anti-B220 (RA3–6B2, BD Biosciences), anti-CD138 (281-2, Biolegend), anti-VpreB (R3, Biolegend), and anti-CD24 (M1/69, Biolegend). FCRL1 expression in different cell types in the bone marrow and spleen was tracked with anti-CD307a (REA566, Miltenyi).
+ Open protocol
+ Expand
5

Immunohistochemical Analysis of EAE Pathology

Check if the same lab product or an alternative is used in the 5 most similar protocols
CNS tissue from naïve + IgG isotype antibody, EAE + IgG isotype antibody or EAE + anti-CLEC12A antibody Day 7 were collected and fixed with 10% formalin and paraffin blocks were prepared. Microtome sections (10 μm) were generated and stained with 1:50 anti-CD11c (clone AP-MAB0806; Novus Biologicals), 1:100 anti-CD11b (polyclonal; Novus Biologicals), 1:50 anti-CD19 (6D5; Biolegend) and 1:50 anti-MOG antibody (polyclonal; Thermo Scientific). Brain tissue was further subjected to Luxol Fast Blue/Cresyl Violet staining (Novaultra), followed by hematoxylin & eosin (Polyscientific).
+ Open protocol
+ Expand
6

Comprehensive Flow Cytometry Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used in flow cytometry with the indicated antibody clones and manufacturers for the mouse experiments: Anti-CD3 (17A2; BD Biosciences), anti-CD19 (6D5; BioLegend), anti-CD11c (clone: N418; Biolegend), anti-CD11b (M1/70; BioLegend), anti-CD49b (DX5; eBioscience), anti-CD25 (PC61; BD Biosciences), anti-CD90.2 (anti-Thy-1.2; 53 2.1; eBioscience), anti-CD11c (N418; eBioscience), anti-ST2 (DIH9; BioLegend), anti-Siglec-F (clone: E50-2440; Biolegend) anti-CD4 (RM4-5; BD Biosciences), anti-IL-13 (ebio13A, eBioscience), anti-Foxp3 (FJK-16S; eBioscience), anti-CD62L(MEL-14; eBioscience), LGR6 (17658-1-AP; Proteintech). Flow cytometric data acquisition was performed on an LSRFortessa flow cytometer (BD Biosciences), and the data analyzed using FlowJo software version 10.3 (Tree Star). The gating strategy is provided in SI Appendix, Fig. S7 for populations analyzed.
+ Open protocol
+ Expand
7

Multiparameter Flow Cytometry of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolated cells from thymic glands, PDLNs, and spleens were stained with the following antibodies: anti‐CD11b (M1/70; BioLegend), anti‐CD11c (N418; BioLegend), anti‐PDCA‐1 (129c1; BioLegend), anti‐Ly6G (1A8; BioLegend), anti‐CD8ɑ (53‐6.7; BD BioSciences), anti‐B220 (RA3‐6B2; BioLegend), anti‐CD19 (1D3; BD BioSciences), anti‐CD19 (6D5; BioLegend), anti‐CD5 (53‐7.3; BD BioSciences), anti‐CD21 (7E9; BioLegend), anti‐CD3 (17A2; BioLegend), anti‐NK1.1 (PK136; BioLegend), anti‐NKp46 (29A1.4; BioLegend), and anti‐IFN‐γ (XMG1.2; BioLegend). Dilutions, catalogue numbers, and RRIDs of antibodies are given in Table S1. The stained cells were analyzed by a LSR Fortessa at the BioVis core facility, Uppsala University, Uppsala, Sweden. Single stained, unstained, and Fluorescence Minus One controls were applied as negative controls to identify any spread of the fluorochromes into the channel of interest and to properly gate the fluorochromes. The data were analyzed by Flowlogic software (Inivai Technologies). Gating strategies for flow cytometric analysis for different cell types are shown in Figures S2‐S6.
+ Open protocol
+ Expand
8

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cell sorting and flow cytometry analysis, cell suspension were prepared as described above, incubated with fixable viability dye and subsequently stained with following fluorophore-conjugated monoclonal antibodies: anti-CD45 (30-F11, BD Biosciences), anti-CD45.2 (104, Biolegend), anti-CD90.2 (thy1.2) (53–2.1, Biolegend), anti-CD3 (17A2, Biolegend), anti-CD4 (Biolegend, RM4–5), anti-CD8 (53–6.7, Biolegend), anti-CD11b (M1/70; Biolegend), anti-CD11c (N418, Biolegend), anti-Ly6C (HK1.4, Biolegend), anti-Ly6G (1A8, BD Biosciences), anti-Siglec-F (E50–2440, BD Bioscience), anti-mouse MHC Class II (I-A/I-E) (M5/114.15.2, eBioscience), anti-NK1.1 (PK136, Biolegend), anti-CD19 (6D5, Biolegend), anti-T1/ST2 (DJ8, MD Biosciences), anti-KLRG1 (2F1, Biolegend), anti-FoxP3 (FJK-16S, eBiosciences), anti-Ki-67 (16A8, Biolegend), anti-Gata3 (TWAJ, eBioscience), anti-IL13 (eBio13A, eBioscience), anti-IFNgR1 (XMG1.2, BD Bioscience).
+ Open protocol
+ Expand
9

Multiparametric Flow Cytometry Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cell surface staining, cells were pre-incubated with 2.4G2 Fcγ RII/RIII blocking mAb for 15 minutes and then stained with the appropriate combinations of mAbs diluted in HBSS + 2% FBS for 30 minutes at 4°C. Cells were analyzed on a BD FACS CantoII, or Cytek Aurora Spectral Cytometer and data were processed with FlowJo software (TreeStar). The complete list of antibodies use is as follows: anti-human Vβ5.1 (LC4, Invitrogen), anti-TCRβ (H57–597, BioLegend), anti-CD44 (IM7, BioLegend), anti-Vβ11 (KT11, BioLegend), anti-CD45.2 (104, BioLegend), anti-CD45.1 (A20, BioLegend), anti-SiglecF (E50–2440, BD Bioscience), anti-CD45 (30-F11, BioLegend), anti-CD11c (N418, BioLegend), anti-CD11b (M1/70, BioLegend), anti-Ly6G (1A8, BioLegend), anti-CD19 (6D5, BioLegend), anti-NK1.1 (PK136, BioLegend), anti-CD3 (17A2, BioLegend), Zombie Red (BioLegend), anti-mouse CD185/CXCR5 (L138D7, Biolegend), anti-mouse CD279/PD-1 (29F.1A12, Biolegend), and anti-Ki67 (SolA15, Invitrogen).
+ Open protocol
+ Expand
10

Isolation of Wound Cell Populations

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were dissociated from excisional wounds using an enzymatic digest with collagenase I, collagenase XI, and hyaluronidase [18] (link). Neutrophils, T cells, and B cells were marked for depletion by incubating cells for 15 min with fluorescein isothiocyanate (FITC)-conjugated anti-Ly6G (1A8), anti-CD3 (17A2), and anti-CD19 (6D5) (1∶10; Biolegend); these cells were depleted from the total cell population using anti-FITC magnetic beads and by following the manufacturer's instructions (Miltenyi Biotec). Cells of the monocyte/macrophage lineage were then isolated using CD11b magnetic beads. Both CD11b+ and CD11b− cell fractions were collected and then stored at −80°C for later RNA analysis. Previous studies indicated that >90% of the CD11b+ cells thus isolated were positive for monocyte/macrophage markers Ly6C and/or F4/80 by flow cytometry [18] (link). The CD11b− cell fraction likely consists mainly of fibroblasts, endothelial cells and keratinocytes.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!